Category stocks

Xerox Q2 Earnings Call Highlights

Key Points - Revenue rose 22% year over year to $1.92 billion in Q2 2026, driven by the Lexmark acquisition, although pro forma revenue declined nearly 7%. Adjusted operating margin improved to 10.6%, helped by $105 million in tariff receivables and Lexmark integration syn

Pharming Group Q2 Earnings Call Highlights

Key Points - Pharming cut its 2026 outlook, forecasting revenue of $375 million to $395 million after second-quarter revenue fell 3% to $90.2 million. The company also lowered its operating-expense forecast by $15 million, while expecting RUCONEST sales to stabilize and re

Sanofi Q2 Earnings Call Highlights

Key Points - Sanofi raised its 2026 outlook after second-quarter sales rose 17.8% to €11.6 billion and business EPS increased 33.3%, driven by Dupixent, new medicines and cost discipline. - Dupixent quarterly sales surpassed €5 billion, up 37%, prompting Sanofi to lift its 2030...</strong

Neogen Q4 Earnings Call Highlights

Key Points - Q4 performance improved: Neogen reported $225.3 million in revenue, with core growth accelerating to 4.3%. Food safety led results with 5.8% core growth, while adjusted EBITDA rose 12% to $45.4 million. - Fiscal 2027 will emphasize investment and growth: The c